These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 41280

  • 21. Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.
    Nickolson VJ, Wieringa JH, van Delft AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):48-55. PubMed ID: 6287300
    [No Abstract] [Full Text] [Related]

  • 22. Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.
    Elliott HL, McLean K, Sumner DJ, Reid JL.
    Eur J Clin Pharmacol; 1983 Apr; 24(1):15-9. PubMed ID: 6299752
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of mianserin on noradrenergic mechanisms.
    Rose A, McCulloch MW, Sarantos-Laska C, Rand MJ.
    J Psychiatr Res; 1984 Apr; 18(1):79-88. PubMed ID: 6716316
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of yohimbine, mianserin, chlorpromazine and prazosin as antagonists of the suppressant effect of clonidine on operant behavior.
    Dwoskin LP, Sparber SB.
    J Pharmacol Exp Ther; 1983 Jul; 226(1):57-64. PubMed ID: 6864550
    [No Abstract] [Full Text] [Related]

  • 29. The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat.
    Jancsár SM, Leonard BE.
    Neuropharmacology; 1984 Sep; 23(9):1065-70. PubMed ID: 6083502
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of mianserin on noradrenergic transmission in the rat anococcygeus muscle.
    Doggrell SA.
    Br J Pharmacol; 1980 Feb; 68(2):241-50. PubMed ID: 6244037
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Opposite effects on human distal colon motility of two postulated alpha 2-antagonists (mianserin and chlorprothixene) and one alpha 2-agonist (clonidine).
    Lechin F, van der Dijs B.
    J Clin Pharmacol; 1983 Feb; 23(5-6):209-18. PubMed ID: 6875022
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacodynamic studies on mianserin and its interaction with clonidine.
    Elliott HL, McLean K, Sumner DJ, Reid JL.
    Eur J Clin Pharmacol; 1981 Feb; 21(2):97-102. PubMed ID: 7341285
    [Abstract] [Full Text] [Related]

  • 39. Interaction between mianserin and clonidine at alpha 2-adrenoceptors.
    Pommier Y, Andréjak M, Mouillé P, Dabiré H, Lucet B, Schmitt H.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Mar; 318(4):288-94. PubMed ID: 6281667
    [Abstract] [Full Text] [Related]

  • 40. Acute and long-term regulation of brain alpha 2-adrenoceptors after manipulation of noradrenergic transmission in the rat.
    Giralt MT, García-Sevilla JA.
    Eur J Pharmacol; 1989 May 30; 164(3):455-66. PubMed ID: 2569977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.